Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

The CAALA (Complex Augmentation of ALA) regimen was developed with the goal of redressing some of the weaknesses of 5-aminolevulinic acid (5-ALA) use in glioblastoma treatment as it now stands. 5-ALA is approved for use prior to glioblastoma surgery to better demarcate tumor from brain tissue. 5-ALA...

Full description

Bibliographic Details
Main Authors: Richard E. Kast, Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Hessling, Guido Frosina, Anton P. Kast, Georg Karpel-Massler, Marc-Eric Halatsch
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Brain Sciences
Subjects:
5-aminolevulinic acid
ciprofloxacin
deferiprone
fluorescence
5-fluorouracil
febuxostat
glioblastoma
photodynamic treatment
temozolomide,
Online Access:https://www.mdpi.com/2076-3425/8/12/203

Similar Items

Similar Items